Accounts Receivable, after Allowance for Credit Loss, Current in USD of ABVC BIOPHARMA, INC. from Q3 2012 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.
Summary
Abvc Biopharma, Inc. quarterly Accounts Receivable, after Allowance for Credit Loss, Current history and change rate from Q3 2012 to Q3 2024.
  • Abvc Biopharma, Inc. Accounts Receivable, after Allowance for Credit Loss, Current for the quarter ending 30 Sep 2024 was $1.53K, a 0.07% decline year-over-year.
Accounts Receivable, after Allowance for Credit Loss, Current, Quarterly (USD)
Accounts Receivable, after Allowance for Credit Loss, Current, YoY Quarterly Change (%)

ABVC BIOPHARMA, INC. Quarterly Accounts Receivable, after Allowance for Credit Loss, Current (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2024 $1.53K -$1 -0.07% 30 Sep 2024 10-Q 14 Nov 2024
Q2 2024 $1.53K -$10.8K -87.6% 30 Jun 2024 10-Q 14 Aug 2024
Q1 2024 $1.53K -$123K -98.8% 31 Mar 2024 10-Q 17 May 2024
Q4 2023 $1.53K -$96.8K -98.4% 31 Dec 2023 10-K 15 Apr 2025
Q3 2023 $1.53K -$46.2K -96.8% 30 Sep 2023 10-Q 15 Nov 2023
Q2 2023 $12.4K -$277K -95.7% 30 Jun 2023 10-Q 14 Aug 2023
Q1 2023 $124K -$157K -55.9% 31 Mar 2023 10-Q 15 May 2023
Q4 2022 $98.3K -$182K -65% 31 Dec 2022 10-K 13 Mar 2024
Q3 2022 $47.7K -$284K -85.6% 30 Sep 2022 10-Q 14 Nov 2022
Q2 2022 $289K -$7.55K -2.54% 30 Jun 2022 10-Q 15 Aug 2022
Q1 2022 $281K -$111K -28.4% 31 Mar 2022 10-Q 16 May 2022
Q4 2021 $281K +$121K +75.7% 31 Dec 2021 10-K 31 Mar 2023
Q3 2021 $331K 30 Sep 2021 10-Q 15 Nov 2021
Q2 2021 $297K 30 Jun 2021 10-Q 12 Aug 2021
Q1 2021 $393K 31 Mar 2021 10-Q 10 May 2021
Q4 2020 $160K 31 Dec 2020 10-K 31 Mar 2022
Q2 2015 $0 -$1.24K -100% 30 Jun 2015 10-Q 19 Aug 2015
Q1 2015 $2.26K +$1.02K +82.6% 31 Mar 2015 10-Q 05 Jun 2015
Q4 2014 $0 -$1.24K -100% 31 Dec 2014 10-Q 17 Apr 2015
Q3 2014 $0 $0 30 Sep 2014 10-Q 19 Aug 2015
Q2 2014 $1.24K $0 0% 30 Jun 2014 10-Q 17 Apr 2015
Q1 2014 $1.24K $0 0% 31 Mar 2014 10-Q 17 Apr 2015
Q4 2013 $1.24K $0 0% 31 Dec 2013 10-Q 17 Apr 2015
Q3 2013 $0 $0 30 Sep 2013 10-Q 17 Apr 2015
Q2 2013 $1.24K 30 Jun 2013 10-Q 16 Apr 2015
Q1 2013 $1.24K 31 Mar 2013 10-Q 16 Apr 2015
Q4 2012 $1.24K 31 Dec 2012 10-Q 16 Apr 2015
Q3 2012 $0 30 Sep 2012 10-K 16 Apr 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.